An update on respiratory syncytial virus epidemiology: a developed country perspective

被引:108
作者
Law, BJ
Carbonell-Estrany, X
Simoes, EAF
机构
[1] Univ Manitoba, Dept Pediat & Child Hlth, Winnipeg, MB R3T 2N2, Canada
[2] Inst Clin Ginecol, Hosp Clin, Barcelona, Spain
[3] Univ Colorado, Sch Med, Dept Pediat, Infect Dis Sect, Denver, CO USA
[4] Childrens Hosp, Denver, CO 80218 USA
关键词
lower respiratory tract infection; prematurity; palivizumab; prophylaxis; respiratory syncytial virus; epidemiology;
D O I
10.1053/rmed.2002.1294
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections in infants and young children worldwide, and an important cause of morbidity, hospitalization, and mortality. The infections caused by RSV are seasonal, peaking predictably in the winter months in temperate climates, and in the hottest months and the rainy season in tropical climates. The involvement of the lower respiratory tract, manifest clinically as bronchiolitis or pneumonia, is the hallmark of severe RSV disease, Other indicators of severe disease include requirement for, and duration of, hospitalization, supplemental oxygen, management in an intensive care setting, and mechanical ventilation, Host-related risk factors for severe RSV disease include preterm birth, infection before 6 months of age, chronic lung disease, and congenital heart disease, Environmental risk factors for severe RSV infection include poverty, crowding, exposure to tobacco smoke, and malnutrition, Factors that increase frequency of the infection include young age, multiple gestation, family history of atopy, lack of parental education, household crowding, older school-age siblings, lack of breast feeding, day-care attendance, passive smoke exposure, and discharge from a neonatal intensive care unit between September and December, Recent studies in Europe, North America and Japan have evaluated the number of children affected as well as the medical resources necessary to care for these children. Continuing surveillance is the key to tracking the seasonality, risk factors, morbidity and mortality associated with RSV infection. Epidemiological studies are also the basis for development of appropriate local prevention strategies. (C) 2002 Elsevier Science Ltd.
引用
收藏
页码:S1 / S7
页数:7
相关论文
共 29 条
  • [1] Variable morbidity of respiratory syncytial virus infection in patients with underlying lung disease: a review of the PICNIC RSV database
    Arnold, SR
    Wang, EEL
    Law, BJ
    Boucher, FD
    Stephens, D
    Robinson, JL
    Dobson, S
    Langley, JM
    McDonald, J
    MacDonald, NE
    Mitchell, I
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1999, 18 (10) : 866 - 869
  • [2] International variation in the management of infants hospitalized with respiratory syncytial virus
    Behrendt, CE
    Decker, MD
    Burch, DJ
    Watson, PH
    [J]. EUROPEAN JOURNAL OF PEDIATRICS, 1998, 157 (03) : 215 - 220
  • [3] Rates of hospitalization for respiratory syncytial virus infection among children in Medicaid
    Boyce, TG
    Mellen, BG
    Mitchel, EF
    Wright, PF
    Griffin, MR
    [J]. JOURNAL OF PEDIATRICS, 2000, 137 (06) : 865 - 870
  • [4] Local variability in respiratory syncytial virus disease severity
    Brandenburg, AH
    Jeannet, PY
    vonSteenselMoll, HA
    Ott, A
    Rothbarth, PH
    Wunderli, W
    Suter, S
    Neijens, HJ
    Osterhaus, ADME
    Siegrist, CA
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 1997, 77 (05) : 410 - 414
  • [5] Hospitalization rates for respiratory syncytial virus infection in premature infants born during two consecutive seasons
    Carbonell-Estrany, X
    Quero, J
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2001, 20 (09) : 874 - 879
  • [6] BRONCHIOLITIS IN TROPICAL SOUTH-INDIA
    CHERIAN, T
    SIMOES, EAF
    STEINHOFF, MC
    CHITRA, K
    JOHN, M
    RAGHUPATHY, P
    JOHN, TJ
    [J]. AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1990, 144 (09): : 1026 - 1030
  • [7] CHEZZI C, 2001, 5 WORLD C PER MED 23
  • [8] Respiratory syncytial virus infection in high risk infants and the potential impact of prophylaxis in a United Kingdom cohort
    Clark, SJ
    Beresford, MW
    Subhedar, NV
    Shaw, NJ
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 2000, 83 (04) : 313 - 316
  • [9] CUNNINGHAM CK, 1991, PEDIATRICS, V88, P527
  • [10] DUCOFFRE G, 2001, 5 WORLD C PER MED 23